| 1,25(OH)2D | 1,25-dihydroxyvitamin D |
| 25(OH)D | 25-hydroxyvitamin D |
| BP-MRONJ | Bisphosphonate-related osteonecrosis of the jaw |
| CKD | Chronic kidney disease |
| FGF23 | Fibroblast growth factor 23 |
| LL-37 | Cathelicidin antimicrobial peptide LL-37 |
| MRONJ | Medication-related osteonecrosis of the jaw |
| mTOR | Mechanistic target of rapamycin |
| ONJ | Osteonecrosis of the jaw |
| OPG | Osteoprotegerin |
| ORN | Osteoradionecrosis |
| RANK | Receptor activator of nuclear factor kappa-B |
| RANKL | Receptor activator of nuclear factor kappa-B ligand |
| RUNX2 | Runt-related transcription factor 2 |
| TNF-α | Tumor necrosis factor alpha |
| VDR | Vitamin D receptor |
| VEGF | Vascular endothelial growth factor |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.